NUTM2F

Across TCGA pan-cancer cohorts, NUTM2F RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of NUTM2F’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where NUTM2F RNA is more highly expressed in tumor relative to normal tissue. In most cancer types NUTM2F is over-expressed in tumor, although a few such as KICH and LUAD show the opposite, repressed pattern.

HNSC, KICH, and LUAD are the cancer types where NUTM2F tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in NUTM2F RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	II,III,IV	+0.084	<.001	11	view →
KICH	All	All	−0.084	<.001	8	view →
LUAD	All	III,IV	−0.056	<.001	6	view →
BRCA	Female	All	+0.024	.021	4	view →
LUSC	All	All	+0.085	<.001	3	view →
PRAD	All	All	+0.111	<.001	2	view →
STAD	Male	II,III,IV	+0.037	.023	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

NUTM2F–HNSC

Open the HNSC breakdown →